COSMOS Pharmaceutical Corporation (3349.T)

9053.0035.00 (-0.39%)

COSMOS Pharmaceutical Corporation (3349.T) stock comprehensive Liquidity Coverage Analysis including current ratio, quick ratio, cash ratio, interest coverage ratio, gross margin, operating margin, net margin, return on assets, return on equity, return on invested capital. Compare liquidity against peers/competitors, industry and sector standards.

Low Bankruptcy RiskLow ProfitabilityEfficient OperationsModerate GrowthModerate QualityAdequate Dividend ProfileIndustry Rank: 67.57%Sector Rank: 75.68%

JPX - Healthcare - Medical - Pharmaceuticals | Market Cap: 717.52B | Next Earnings Date: 14 Oct 2025

Day's Range

8935.00 - 9125.00

52-Week Range

6347.00 - 10045.00

Volume

380.0K / 335.9K (Avg.)

P/E Ratio | EPS

23.15 | 391.09

Trending:

3349.T Liquidity & Coverage Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Highlights the firm's ability to meet near-term obligations and cover interest expenses. For conservative value investors, strong liquidity and coverage metrics are critical to avoid distress or forced dilution.

Current Ratio

0.90

Current Ratio 0.5–0.75x Healthcare median of 1.45. Guy Spier would worry about potential short-term pinch.

Quick Ratio

0.36

Quick Ratio below 0.5x Healthcare median of 1.22. Jim Chanos might see a liquidity gap if the firm cannot tap more credit swiftly.

Cash Ratio

0.28

Cash Ratio 0.75–0.9x Healthcare median of 0.34. John Neff could push for improved balance sheet strength.

Interest Coverage Ratio

38.17

Decreased from previous period

Interest coverage of 38.17 versus zero Healthcare median. Walter Schloss would verify if our debt service capacity provides advantages.

Short-Term Coverage Ratio

-0.98

Negative short-term coverage while Healthcare median is 0.00. Seth Klarman would scrutinize cash flow quality and look for immediate refinancing solutions.

Select Chart Metric: